Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population.

Eishi Oskouei A, Rafiee L, Mahzouni P, Gharipour M, Javanmard SH.

J Res Med Sci. 2018 Nov 28;23:96. doi: 10.4103/jrms.JRMS_305_18. eCollection 2018.

2.

Effects of selenium supplementation on expression of SEPP1 in mRNA and protein levels in subjects with and without metabolic syndrome suffering from coronary artery disease: Selenegene study a double-blind randomized controlled trial.

Gharipour M, Ouguerram K, Nazih EH, Salehi M, Behmanesh M, Roohafza H, Hosseini SM, Nezafati P, Dianatkhah M, Gharipour A, Haghjoo S, Sarrafzadegan N, Sadeghi M.

J Cell Biochem. 2018 Nov;119(10):8282-8289. doi: 10.1002/jcb.26844. Epub 2018 Jun 22.

PMID:
29932230
3.

Use of lipid-lowering medicinal herbs during pregnancy: A systematic review on safety and dosage.

Rouhi-Boroujeni H, Heidarian E, Rouhi-Boroujeni H, Khoddami M, Gharipour M, Rafieian-Kopaei M.

ARYA Atheroscler. 2017 May;13(3):135-155. Review.

4.

Selenium Homeostasis and Clustering of Cardiovascular Risk Factors: A Systematic Review.

Gharipour M, Sadeghi M, Behmanesh M, Salehi M, Nezafati P, Gharpour A.

Acta Biomed. 2017 Oct 23;88(3):263-270. doi: 10.23750/abm.v88i3.5701. Review.

PMID:
29083329
5.

Predicting body mass index in women: The value of the psychological components of depression, anxiety, dietary restraint, and nutritional habits.

Esfahani BN, Kolahdouzan M, Aflakseir A, Gharipour M.

J Educ Health Promot. 2017 Apr 19;6:9. doi: 10.4103/jehp.jehp_247_13. eCollection 2017.

6.

Is herbal therapy safe in obesity? A case of Apium graveolens (Celery) induced hyperthyroidism.

Rouhi-Boroujeni H, Hosseini M, Gharipour M, Rouhi-Boroujeni H.

ARYA Atheroscler. 2016 Sep;12(5):248-249.

7.

Changes in intraocular pressure after exercise test.

Esfahani MA, Gharipour M, Fesharakinia H.

Oman J Ophthalmol. 2017 Jan-Apr;10(1):17-20. doi: 10.4103/0974-620X.200689.

8.

Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.

Gharipour M, Sadeghi M, Salehi M, Behmanesh M, Khosravi E, Dianatkhah M, Haghjoo Javanmard S, Razavi R, Gharipour A.

J Gene Med. 2017 Mar;19(3). doi: 10.1002/jgm.2945.

PMID:
28190280
9.

Socioeconomic determinants and metabolic syndrome: Results from the Isfahan Healthy Heart Program.

Gharipour M, Sadeghi M, Nouri F, Nezafati P, Qader SS, Taheri M, Maghroun M, Abdalvand A, Soleimani B, Sarrafzadegan N.

Acta Biomed. 2017 Jan 16;87(3):291-198.

PMID:
28112697
10.

Assessing Metabolic Syndrome Through Increased Heart Rate During Exercise.

Sadeghi M, Gharipour M, Nezafati P, Shafie D, Aghababaei E, Sarrafzadegan N.

Acta Med Iran. 2016 Nov;54(11):724-730.

11.

Is there any relationship between different phenotypes of metabolic syndrome and cardiovascular mortality rate?

Khosravi A, Ahmadzadeh S, Gharipour M, Golshahi J, Sadeghi M, Jozan M, Sarrafzadegan N.

Adv Biomed Res. 2016 Nov 28;5:185. doi: 10.4103/2277-9175.192727. eCollection 2016.

12.

Metabolic Syndrome and the Risk of Ischemic Stroke.

Sarrafzadegan N, Gharipour M, Sadeghi M, Nezafati P, Talaie M, Oveisgharan S, Nouri F, Khosravi A.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):286-294. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.019. Epub 2016 Oct 18.

PMID:
27769610
13.

The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition.

Sheikhbahaie F, Amini M, Gharipour M, Aminoroaya A, Taheri N.

Adv Biomed Res. 2016 Aug 30;5:145. doi: 10.4103/2277-9175.187401. eCollection 2016.

14.

Paternal or maternal history of hypertension is more important in increasing the risk of hypertension inoffspring?

Khosravi A, Gharipour M, Behjati M, Sadeghi M, Nezafati P, Talaie M, Shirani S, Jozan M.

Acta Biomed. 2016 Sep 13;87(2):161-7.

PMID:
27648998
15.

Pre-hypertension, pre-diabetes or both: which is best at predicting cardiovascular events in the long term?

Khosravi A, Gharipour M, Nezafati P, Khosravi Z, Sadeghi M, Khaledifar A, Taheri M, Golshahi J, Sarrafzadegan N.

J Hum Hypertens. 2017 Jun;31(6):382-387. doi: 10.1038/jhh.2016.42. Epub 2016 Jun 23.

PMID:
27334522
16.

Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes.

Gharipour M, Sadeghi M, Dianatkhah M, Nezafati P, Talaie M, Oveisgharan S, Golshahi J.

J Clin Lipidol. 2016 Jan-Feb;10(1):143-9. doi: 10.1016/j.jacl.2015.10.008. Epub 2015 Oct 24.

PMID:
26892131
17.

Advanced method used for hypertension's risk factors stratiļ¬cation: support vector machines and gravitational search algorithm.

Khosravi A, Gharipour A, Gharipour M, Khosravi M, Andalib E, Shirani S, Mirmohammadsedeghi M.

ARYA Atheroscler. 2015 Nov;11(6):349-56.

18.

Main clinical determinants of the presence of coronary artery disease in patients with left bundle branch block.

Hashemi Jazi M, Nilforoush P, Gharipour M, Batvandi A, Mohammadi R, Najafi R.

Acta Biomed. 2015 Dec 15;86(3):267-72.

PMID:
26694154
19.

Metabolic syndrome and its association with left ventricular dysfunction in patients with left bundle branch block.

Gharipour M, Hashemi Jazi M, Nilforoush P, Batvandi A, Mohammadi R, Najafi R.

Acta Biomed. 2015 Sep 14;86(2):157-61.

PMID:
26422430
20.

Systematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist.

Rouhi-Boroujeni H, Rouhi-Boroujeni H, Gharipour M, Mohammadizadeh F, Ahmadi S, Rafieian-Kopaei M.

Acta Biomed. 2015 Sep 14;86(2):130-6. Review.

PMID:
26422426

Supplemental Content

Loading ...
Support Center